TRT Side Effects and Risks: What the Evidence Says


Is TRT safe? For men with confirmed low testosterone who are carefully chosen and monitored, the best current evidence says the major risks are lower than once feared, but testosterone therapy isn’t risk-free. The most common TRT side effect is a rise in red blood cell concentration (hematocrit). Others include acne, fluid retention, breast tenderness, worse sleep apnea and smaller testes, and TRT suppresses sperm production. The largest heart-safety trial, TRAVERSE, found no increase in heart attack, stroke or cardiovascular death, but did find more atrial fibrillation, kidney injury and blood clots in the lungs. Regular monitoring is how these risks get caught early.
This guide covers testosterone replacement therapy side effects one by one, what the evidence says about each, and how monitoring keeps them in check. If you’re still deciding whether TRT is right for you, start with our testosterone replacement therapy guide.
TRT risks at a glance
Common side effects of testosterone replacement therapy
These are the side effects men notice most often, drawn from FDA labeling and MedlinePlus:
- Acne and oily skin. Common, especially early on.
- Fluid retention. Swelling in the ankles, feet or hands. The gel label warns that this swelling, “with or without congestive heart failure, may be a serious complication” (prescribing information).
- Breast tenderness or enlargement. The label notes breast enlargement “may develop and persist”. It’s often linked to estradiol; our page on hormonal imbalance in men explains why. A new breast lump always needs checking, and our post on breast cancer in men explains what to look for.
- Worse sleep apnea. Testosterone “may potentiate sleep apnea in some patients, especially those with risk factors such as obesity”. If you snore heavily, ask about a sleep study before starting. Our post on sleep apnea in men covers the signs.
- Smaller testes. Outside testosterone turns down the signals from your pituitary, so the testes make less of their own.
- Effects tied to the form. Pain or bruising at injection sites; infection or a pellet working its way out with pellets (pellet prescribing information); and with gels, the risk of passing testosterone to partners or children, which carries an FDA boxed warning.
Heart health: what TRAVERSE did and didn’t show

Worry about testosterone and the heart grew after a small trial was stopped early in 2010 and later studies pointed in different directions. After a 2014 advisory meeting, the FDA in 2015 required manufacturers to run a proper safety trial (TCTMD).
That trial was TRAVERSE, published in the New England Journal of Medicine in 2023 (Lincoff et al.). It randomized 5,246 men aged 45 to 80 at 316 US sites. All had symptoms of low testosterone, two testosterone levels below 300 ng/dL, and either heart disease or a high risk of it. They used a daily testosterone gel or a placebo gel. Treatment lasted 21.7 months on average, with 33 months of follow-up.
What it showed:
- Major heart events (heart attack, stroke or death from heart causes) happened in 7.0% of the testosterone group and 7.3% of the placebo group. Testosterone didn’t raise the risk.
- Atrial fibrillation (3.5% vs 2.4%), acute kidney injury (2.3% vs 1.5%) and pulmonary embolism, a blood clot in the lungs (0.9% vs 0.5%), were more common with testosterone.
What it didn’t show:
- It tested a gel, not injections or pellets, so it doesn’t directly answer questions about injections.
- It didn’t include men under 45 or men without confirmed low testosterone.
- It wasn’t designed to show a heart benefit. The lead investigator warned against reading it as permission to treat tired men “in a willy-nilly fashion” without testing and monitoring.
In February 2025, the FDA required all testosterone labels to add the TRAVERSE results and remove the boxed warning about increased heart risk. It also required blood pressure warnings, because its own monitoring studies confirmed that testosterone products raise blood pressure (FDA).
Put plainly: for monitored men with true low testosterone, the evidence doesn’t support the idea that TRT causes heart attacks or strokes. Heart rhythm, clots and blood pressure still need watching, and the Endocrine Society advises against starting TRT within 6 months of a heart attack or stroke.
Have heart disease, high blood pressure or a history of clots? Find out whether TRT is appropriate for you and how it would be monitored. See what a low T evaluation involves
Prostate: cancer risk and enlargement
A TRAVERSE substudy of 5,204 men looked specifically at the prostate (Bhasin et al., 2023). High-grade prostate cancer occurred in 0.19% of men on testosterone and 0.12% on placebo, a difference that wasn’t statistically significant. Rates of any prostate cancer, sudden inability to urinate, prostate procedures and urinary symptom scores didn’t differ. PSA rose more in the testosterone group. Men with a PSA above 3.0 ng/mL or severe urinary symptoms weren’t allowed in, so these results apply to screened men.
The Endocrine Society recommends a PSA and prostate exam before starting and 3 to 12 months after, for men 55 to 69 (or 40 to 69 at higher risk) who choose monitoring. It advises a urology referral for a confirmed PSA rise of more than 1.4 ng/mL in the first year, a confirmed PSA above 4 ng/mL, an abnormal exam or much worse urinary symptoms. Our posts on TRT and prostate enlargement and prostate cancer and testosterone therapy, and our prostate health page, go further.
Thicker blood (high hematocrit) and clot risk
Testosterone boosts red blood cell production. The Endocrine Society’s review found a high hematocrit (above 54%) to be one of the most common side effects, and notes that gels cause less of it than injections (Bhasin et al., 2018).
A 2024 review in Endocrine Connections found that the link between a testosterone-related high hematocrit and clots or heart events isn’t firmly established, and that “high-quality evidence is lacking”. It recommends lowering the dose and dealing with other risk factors, such as sleep apnea, before considering blood removal, whose benefit is unproven. Some guidelines, including the European Academy of Andrology’s, call for stopping therapy when hematocrit goes above 54%. Men who already have a high hematocrit or an inherited clotting disorder shouldn’t start TRT.
Fertility
TRT suppresses the hormones that drive sperm production, and some men end up with no sperm in their semen. Most recover within a year of stopping, but recovery isn’t guaranteed (Crosnoe et al., 2013). If you want children, ask about options that support your own production, such as enclomiphene, and read about fertility after testosterone treatment.
Mood and other effects
In men with confirmed low testosterone, treatment often lifts mood. Among testosterone therapy side effects, MedlinePlus still lists mood swings, and less often depression or anxiety, as possible effects. The serious problems, including heart, liver and mental health effects, are linked mainly to doses above what’s prescribed. Tell your provider about any change in mood, sleep or behavior.
How monitoring lowers risk

Most TRT risks show up on routine labs before they become a problem. The Endocrine Society’s schedule:
Good monitoring starts with good testing. Our testosterone test guide and our page on comprehensive hormone testing explain what gets checked.
Who is at higher risk?
The Endocrine Society recommends against TRT for men who:
- Are planning a family in the near future
- Have breast or prostate cancer, a prostate lump, or a raised PSA that hasn’t been checked by a urologist
- Have a high hematocrit or an inherited clotting disorder
- Have untreated severe sleep apnea or severe urinary symptoms
- Have uncontrolled heart failure, or had a heart attack or stroke in the last 6 months
Men who are older, have heart disease or high blood pressure, or carry extra weight and snore need closer monitoring.
What to do if you have TRT side effects
- Don’t stop or change your dose on your own. Call the provider who manages your TRT.
- Get your labs checked. Many side effects trace back to a high testosterone level, high hematocrit or high estradiol, and changing the dose or form often helps.
- Call 911 for chest pain, sudden shortness of breath, swelling or pain in one leg, or signs of a stroke such as a drooping face or slurred speech.
- Report a breast lump, a racing or irregular heartbeat, new snoring or trouble urinating at your next visit, or sooner.
TRT monitoring in Houston
The Y Factor manages testosterone therapy with in-person visits and scheduled labs at our Memorial and The Woodlands clinics. Men come to us from across the area, including Cypress and Sugar Land. If you’re already on TRT elsewhere and aren’t sure your monitoring is on track, a low testosterone evaluation is a good place to start. Our TRT page and our overview of men’s hormone health have more.
Talk to a provider about whether TRT is right for you, what your risks are and how we’d monitor them. Book a low T evaluation

Select Your Men's Health Specialist, Book Instantly
Find expert urologists and men's health professionals who understand your unique needs.
Our streamlined platform helps you connect quickly and confidentially.
Personalized Treatment Plans
Receive tailored recommendations and therapies specifically designed to address your individual health needs.
Ongoing Support & Follow-up
Benefit from continuous care, including regular progress reviews and expert guidance throughout your wellness journey.




.jpg)






